Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Phaim Pharma Logo
Phaim Pharma CB Rank
1069173
Heat Score
39
Phaim Pharma is dedicated to the eradication of type 1 diabetes through a range of new medicines and strategies.
Founded
obfuscation
Private London, England, United Kingdom1-10 www.phaim.co.uk
Biotechnology
Diabetes
Medical
Overview

Phaim Pharma
Heat Score
39

Growth Score
pts
in past quarter
Heat Score 39
-26 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Phaim Pharma

CB Rank
1069173
Phaim Pharma is dedicated to the eradication of type 1 diabetes through a range of new medicines and strategies.
Founded
obfuscation
Private London, England, United Kingdom1-10 www.phaim.co.uk
Biotechnology
Diabetes
Medical

Key People

Details

Legal Name Phaim Pharma Limited
Operating Status Active
Company Type For Profit
Founders  Dr. Heyam Jalahej, Dr. Tihamer Orban, Nara Daubeney, Professor Piers Daubeney
Phone Number 44 207 351 7011
Contact Email contact@phaim.co.uk
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Antigenic Immune Modulation (AIM) Platform
A therapeutic platform designed to reset the immune system to prevent autoimmune diseases by targeting disease-specific antigens.
DMX4001
A drug candidate for Type 1 Diabetes that aims to normalize blood glucose levels and improve T cell function, currently preparing for clinical studies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4

Employee Profiles

News

News and Press

News•Mar 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

264

Active Website Tech Count

9Phaim Pharma is actively using 9 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  HSTS.

Total IP

10The intellectual property of Phaim Pharma includes 6 registered patents primarily in the 'Testing' category, according to IPqwery. Additionally, Phaim Pharma has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Phaim Pharma's headquarters? Phaim Pharma is located in London, England, United Kingdom.Who are Phaim Pharma's competitors? Alternatives and possible competitors to Phaim Pharma may include Vertex Pharmaceuticals, Sana Biotechnology, and  Diamyd Medical.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(a3479ff 1)
|